|
1
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Greef B and Eisen T: Medical treatment of
renal cancer: New horizons. Br J Cancer. 115:505–516. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stahlhut Espinosa CE and Slack FJ: The
role of microRNAs in cancer. Yale J Biol Med. 79:131–140.
2006.PubMed/NCBI
|
|
4
|
Wuchty S, Arjona D, Bozdag S and Bauer PO:
Involvement of microRNA families in cancer. Nuc Acids Res.
40:8219–8226. 2012. View Article : Google Scholar
|
|
5
|
Wang J, Zhang KY, Liu SM and Sen S:
Tumor-associated circulating microRNAs as biomarkers of cancer.
Molecules. 19:1912–1938. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sellitti DF and Doi SQ: MicroRNAs in renal
cell carcinoma. Microrna. 4:26–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iwamoto H, Kanda Y, Sejima T, Osaki M,
Okada F and Takenaka A: Serum miR-210 as a potential biomarker of
early clear cell renal cell carcinoma. Int J Oncol. 44:53–58. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC and Ellinger J: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C, Hu J, Lu M, Gu H, Zhou X, Chen X,
Zen K, Zhang CY, Zhang T, et al: A panel of five serum miRNAs as a
potential diagnostic tool for early-stage renal cell carcinoma. Sci
Rep. 5:76102015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Redova M, Poprach A, Nekvindova J, Iliev
R, Radova L, Lakomy R, Svoboda M, Vyzula R and Slaby O: Circulating
miR-378 and miR-451 in serum are potential biomarkers for renal
cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hauser S, Wulfken LM, Holdenrieder S,
Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E,
Walgenbach-Brünagel G, von Ruecker A, et al: Analysis of serum
microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as
potential biomarkers in renal cell carcinoma. Canc Epidemiol.
36:391–394. 2012. View Article : Google Scholar
|
|
12
|
von Brandenstein M, Pandarakalum JJ, Kroon
L, Loeser H, Herden J, Braun G, Wendland K, Dienes HP, Engelmann U
and Fries JW: MicroRNA 15a, inversely correlated to PKCα, is a
potential marker to differentiate between benign and malignant
renal tumors in biopsy and urine samples. Am J Pathol.
180:1787–1797. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Butz H, Nofech-Mozes R, Ding Q, Khella
HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M and Stewart R:
et alExosomal microRNAs are diagnostic biomarkers and can
mediate cell-cell communication in renal cell carcinoma. Eur Urol
Focus. 2:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brodaczewska KK, Szczylik C, Fiedorowicz
M, Porta C and Czarnecka AM: Choosing the right cell line for renal
cancer research. Mol Canc. 15:832016. View Article : Google Scholar
|
|
15
|
Ryan MJ, Johnson G, Kirk J, Fuerstenberg
SM, Zager RA and Torok-Storb B: HK-2: An immortalized proximal
tubule epithelial cell line from normal adult human kidney. Kidney
Int. 45:48–57. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vlasov P, Doi SQ and Sellitti DF: FRTL-5
rat thyroid cells release thyroglobulin sequestered in exosomes: A
possible novel mechanism for thyroglobulin processing in the
thyroid. J Thyroid Res. 2016:92764022016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schwarzenbach H, da Silva AM, Calin G and
Pantel K: Data normalization strategies for microRNA
quantification. Clin Chem. 61:1333–1342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Dai Y, Yang J, Chen T, Yin Y,
Tang M, Hu C and Zhang L: Microarray analysis of microRNA
expression in renal clear cell carcinoma. Eur J Surg Oncol.
35:1119–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juan D, Alexe G, Antes T, Liu H,
Madabhushi A, Delisi C, Ganesan S, Bhanot G and Liou LS:
Identification of a microRNA panel for clear-cell kidney cancer.
Urology. 75:835–841. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jung M, Mollenkopf HJ, Grimm C, Wagner I,
Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach
H, et al: MicroRNA profiling of clear cell renal cell cancer
identifies a robust signature to define renal malignancy. J Cell
Mol Med. 13:3918–3928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: Significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Petillo D, Kort EJ, Anema J, Furge KA,
Yang XJ and The BT: MicroRNA profiling of human kidney cancer
subtypes. Int J Oncol. 35:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weng L, Wu X, Gao H, Mu B, Li X, Wang JH,
Guo C, Jin JM, Chen Z, Covarrubias M, et al: MicroRNA profiling of
clear cell renal cell carcinoma by whole-genome small RNA deep
sequencing of paired frozen and formalin-fixed, paraffin-embedded
tissue specimens. J Pathol. 222:41–51. 2010.PubMed/NCBI
|
|
24
|
Huang X, Liang M, Dittmar R and Wang L:
Extracellular microRNAs in urologic malignancies: Chances and
challenges. Int J Mol Sci. 14:14785–14799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Canc Res. 75:1322–1331. 2015. View Article : Google Scholar
|
|
26
|
Chanudet E, Wozniak MB, Bouaoun L, Byrnes
G, Mukeriya A, Zaridze D, Brennan P, Muller DC and Scelo G:
Large-scale genome-wide screening of circulating microRNAs in clear
cell renal cell carcinoma reveals specific signatures in late-stage
disease. Int J Cancer. 141:1730–1740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Orang AV, Safaralizaden R and Hosseinpour
Feizi MA: Insights into the diverse roles of miR-205 in human
cancers. Asian Pac J Cancer Prev. 15:577–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang
SZE, Ren XB and Cao S: Mir-205 in cancer: An angel or a devil? Eur
J Cell Biol. 92:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guduric-Fuchs J, O'Conner A, Camp B,
O'Neill CL, Medina RJ and Simpson DA: Selective extracellular
vesicle-mediated export of an overlapping set of microRNAs from
multiple cell types. BMC Genomics. 13:3572012. View Article : Google Scholar : PubMed/NCBI
|
